A special MRI scan to aim radiation at low oxygen parts of a brain tumor
Official title: Hypoxia-targeted Radiotherapy Boost for GBM
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study tests whether a special MRI scan can find low oxygen spots in a brain tumor so radiation can be aimed at them.
Read our full plain-language summary
What the trial team says
The purpose of this study is to evaluate the use of dynamic contrast-enhanced MRI (DSC-MRI) to identify and target hypoxic tumor regions in glioblastoma (GBM). The study is divided into two phases: Phase 1 will focus on biologic validation in newly diagnosed GBM patients, while Phase 2 will assess the clinical implementation of DSC-MRI-guided radiotherapy in recurrent or postoperative GBM patients. The primary endpoints are the validation of DSC-MRI in identifying hypoxic regions and assessing the safety and efficacy of radiation therapy based on these findings.
Key facts
- Registry number
- NCT07769918
- Stage of testing
- Not applicable
- Conditions studied
- Glioblastoma (GBM)
Where it is running
This trial lists 1 site.
-
New York
- NYU Langone Health (New York)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.